Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

Back

Air Optix® Night and Day® Aqua Therapeutic Wear

NCT05956535·3 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Alcon Research

In this retrospective, real world evidence study, the subjects wore Air Optix Night and Day Aqua (AONDA) soft contact lenses or PureVision 2 (PV2) soft contact lenses as a therapeutic lens for the treatment of a corneal condition with pain in one or both eyes as part of their eye care professional's treatment and management plan.

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Diagnosis of a corneal condition with pain for which AONDA or PV2 contact lenses were placed on one or both eye(s) as a therapeutic contact lens at Baseline.
Baseline and Follow-up (up to 1 year from Baseline) charts available.

You may not be if

Had a condition (pathological, behavioral, and/or situational) that contraindicated therapeutic CL wear or confounds study results during the data collection period.
Used systemic or ocular medication that would confound study results during the data collection period.

The record

StatusCompleted

PhaseNo phase

Taking part168

StartedSep 2023

UpdatedNov 13, 2024

Conditions

Bullous Keratopathy Corneal Erosion Entropion Corneal Edema Corneal Dystrophy

Where3

Delray Physician Care Center
Delray Beach, Florida, United States
Koetting Associates
St Louis, Missouri, United States
Contact Alcon Call Center For Trial Locations
Fort Worth, Texas, United States

Clareo Health | Air Optix® Night and Day® Aqua Therapeutic Wear